A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease
- 25 May 2005
- journal article
- clinical trial
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 59 (6) , 665-671
Abstract
One option for patients with symptoms of gastroesophageal reflux disease (GERD) is treatment with proton pump inhibitors without prior endoscopy. Continuous or on-demand maintenance therapy are options for symptom-free patients. This study assessed the efficacy of three different treatment options in GERD patients in Norway. About 395 General Practitioners enrolled 2156 patients with symptoms of GERD in an open, randomised, parallel group trial. Following a 4-week symptom control phase [esomeprazole 40 mg once daily (od)], patients received either esomeprazole 20 mg od continuously or on-demand or ranitidine 150 mg twice-daily continuously for 6 months. The percentage of patients with no heartburn at the end of the study was maintained most effectively in the esomeprazole 20 mg continuous group (72.2%) and least effectively in the ranitidine group (32.5%). Significantly, more patients were completely/very satisfied with esomeprazole continuous (82.2%) and esomeprazole on-demand (75.4%) than with ranitidine continuous (33.5%) treatment (p < 0.0001). More patients were kept in remission, symptom free and were overall more satisfied with esomeprazole treatment than ranitidine.Keywords
This publication has 25 references indexed in Scilit:
- Trends in the management of gastro-oesophageal reflux diseasePostgraduate Medical Journal, 1998
- Gastro-oesophageal reflux disease in primary careEuropean Journal of Gastroenterology & Hepatology, 1998
- Endoscopy‐negative acid reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Current practice and future perspectives in the management of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisaprideAlimentary Pharmacology & Therapeutics, 1997
- Heartburn without Oesophagitis: Efficacy of Omeprazole Therapy and Features Determining Therapeutic ResponseScandinavian Journal of Gastroenterology, 1997
- Omeprazole 10 Milligrams Once Daily, Omeprazole 20 Milligrams Once Daily, or Ranitidine 150 Milligrams Twice Daily, Evaluated as Initial Therapy for the Relief of Symptoms of Gastro-oesophageal Reflux Disease in General PracticeScandinavian Journal of Gastroenterology, 1997
- Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findingsEuropean Journal of General Practice, 1995
- Epidemiology and Natural History of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- Symptoms and Endoscopic Findings in the Diagnosis of Gastroesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1987